摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(pentafluorophenyl)-2-propanone | 19225-86-6

中文名称
——
中文别名
——
英文名称
1-(pentafluorophenyl)-2-propanone
英文别名
1-(perfluorophenyl)propan-2-one;1-pentafluorophenyl-2-propanone;2.3.4.5.6-Pentafluor-phenyl-propanon-(2);1-Pentafluorophenylpropan-2-on;1-(Pentafluorophenyl)propan-2-one;1-(2,3,4,5,6-pentafluorophenyl)propan-2-one
1-(pentafluorophenyl)-2-propanone化学式
CAS
19225-86-6
化学式
C9H5F5O
mdl
——
分子量
224.13
InChiKey
UEYLUHZTMXOIMB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    35.5-36.5 °C
  • 沸点:
    42-48 °C(Press: 0.05-0.1 Torr)
  • 密度:
    1.428±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(pentafluorophenyl)-2-propanoneplatinum(IV) oxide 氢气 作用下, 以 甲醇乙醇 为溶剂, 生成 Benzoic acid N'-(1-methyl-2-pentafluorophenyl-ethyl)-hydrazide
    参考文献:
    名称:
    多氟芳族化合物的新反应。第二部分 多氟芳烷基胺
    摘要:
    (±)-苯异丙胺和N-甲基-N-五氟苄基丙-2-炔胺的五氟-(1a)和4-甲氧基-2,3,5,6-四氟-(1b)类似物的制备(25)概述。描述了1-甲基-2-五氟苯基乙基肼(10)和(12)与2-五氟苯基环丙胺(19)的盐的合成。
    DOI:
    10.1039/j39710002062
  • 作为产物:
    描述:
    五氟苯甲醛乙酸铵盐酸三氯化铁铁粉 作用下, 以 为溶剂, 反应 9.0h, 生成 1-(pentafluorophenyl)-2-propanone
    参考文献:
    名称:
    Antimalarial drugs. 60. Synthesis, antimalarial activity, and quantitative structure-activity relationships of tebuquine and a series of related 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1'-biphenyl]-2-ols and N.omega.-oxides
    摘要:
    A series of 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl] [1,1'-biphenyl]-2-ols and N omega-oxides was prepared from the substituted 1-phenyl-2-propanones proceeding through the 5-nitro[1,1'-biphenyl]-2-ols, the corresponding amino, and acetamido derivatives to the N-[5-[(alkylamino)methyl]-6-hydroxy[1,1'-biphenyl]-3-yl]acetamides and final condensation with 4,7-dichloroquinoline or the N-oxide. In a quantitative structure-activity relationship study first run on 28 and later expanded to 40 substituted phenyl analogues and their N omega-oxides, increasing antimalarial potency vs. Plasmodium berghei in mice was found to be correlated with decreasing size (sigma MR) and electron donation (sigma sigma) of the phenyl ring substituents. A significant correlation with N omega-oxidation could not be demonstrated. Initial high activity against P. berghei infections in mice led to expanded studies that demonstrated in addition excellent activity against resistant strains of parasite, activity in primate models, and pharmacokinetic properties apparently allowing protection against infection for extended periods of time even after oral administration. Such properties encourage the clinical trial of a member of this class in man.
    DOI:
    10.1021/jm00156a009
点击查看最新优质反应信息

文献信息

  • NOVEL LINEAR ALPHA-OLEFIN CATALYSTS AND PREPARATION AND USE THEREOF
    申请人:APALENE TECHNOLOGY CO., LTD. (JIAXING)
    公开号:US20180147571A1
    公开(公告)日:2018-05-31
    The present invention relates to a novel linear a-olefin catalyst composition, and preparation and use thereof. The catalyst composition includes a main catalyst and a co-catalyst, wherein the main catalyst is an imino-based iron coordination compound, and the co-catalyst is a mixture of methylaluminoxane, triisobutylaluminum, and borane or GaCl 3 . The catalyst composition can be used to catalyze ethylene oligomerization to produce linear α-olefins having a selectivity of greater than 96%, carbon distribution between C4-C28 with the component of C6-C20 being greater than 75%. The catalyst of the invention is stable in structure and can be used for ethylene oligomerization with high catalytic efficiency. The method of the invention has the advantages of relatively convenient in operation, readily available of raw materials, high yield, low costs, less pollution and easy for industrial production.
    本发明涉及一种新型的线性α-烯烃催化剂组合物,以及其制备和使用。该催化剂组合物包括主催化剂和辅助催化剂,其中主催化剂是一种基于亚胺的铁配位化合物,而辅助催化剂是甲基铝氧烷、三异丁基铝和硼烷或氯化镓的混合物。该催化剂组合物可用于催化乙烯寡聚反应,产生选择性大于96%的线性α-烯烃,碳分布在C4-C28之间,其中C6-C20的组分大于75%。该发明的催化剂结构稳定,可用于高效乙烯寡聚反应。该发明的方法具有操作相对便利、原料易得、产量高、成本低、污染少且易于工业生产的优点。
  • Activation of Alkynes with B(C<sub>6</sub>F<sub>5</sub>)<sub>3</sub> – Boron Allylation Reagents Derived from Propargyl Esters
    作者:Max M. Hansmann、Rebecca L. Melen、Frank Rominger、A. Stephen K. Hashmi、Douglas W. Stephan
    DOI:10.1021/ja4110842
    日期:2014.1.15
    Novel allyl boron compounds are readily synthesized via rearrangement reactions between Lewis acidic B(C6F5)3 and propargyl esters. These reactions proceed through an initial cyclization followed by ring-opening and concurrent C6F5-group migration. In the absence of disubstitution adjacent to the ester oxygen atom, an allyl boron migration rearrangement leads to formal 1,3-carboboration products. These
    通过路易斯酸性 B(C6F5)3 和炔丙酯之间的重排反应,很容易合成新的烯丙基硼化合物。这些反应通过初始环化进行,然后是开环和同时发生的 C6F5 基团迁移。在酯氧原子附近没有二取代的情况下,烯丙基硼迁移重排导致正式的 1,3-碳硼化产物。这些烯丙基硼化合物充当烯丙基化试剂,醛引入 C3-烯丙基片段和 C6F5-单元作为单个反非对映异构体。在这些反应中,B(C6F5)3 激活炔烃,促进重排过程并启用 C6F5 和 R 基团的安装。
  • Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
    申请人:Saksena K. Anil
    公开号:US20070032433A1
    公开(公告)日:2007-02-08
    The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    本发明揭示了具有HCV蛋白酶抑制活性的新化合物,以及制备这些化合物的方法。在另一种实施方式中,本发明揭示了包含这些化合物的药物组合物,以及使用它们治疗与HCV蛋白酶相关的疾病的方法。
  • DISPERSION OF WATER-INSOLUBLE COLORANT, METHOD OF PRODUCING SUBSTANCE CONTAINING WATER-INSOLUBLE COLORANT, FINE PARTICLES OF WATER-INSOLUBLE COLORANT, DISPERSING AGENT FOR WATER-INSOLUBLE COLORANT, AND RECORDING LIQUID, INK SET, PRINTED ARTICLE, METHOD OF FORMING IMAGE AND IMAGE FORMING APPARATUS USING THE SAME
    申请人:SANO Satoshi
    公开号:US20090246481A1
    公开(公告)日:2009-10-01
    A dispersion of a water-insoluble colorant containing: a medium containing water; fine particles of the water-insoluble colorant; and a polymer compound or a surfactant that includes at least one kind of electron-withdrawing group or group of atoms represented by any one of formulae (I) to (IV) as its hydrophilic part: wherein at least one of X 1 and X 2 represents an electron-withdrawing linking group on the condition that when at least one of X 1 and X 2 is not the linking group, the at least one of X 1 and X 2 represents an electron-withdrawing substituent; R 1 represents a hydrogen atom or a substituent; and M represents a hydrogen atom or a metal atom.
    一种水不溶性着色剂的分散体,包括:含水介质;水不溶性着色剂的细小颗粒;以及聚合物化合物或表面活性剂,其包含至少一种电子吸引基团或由式(I)至(IV)中的任何一种原子团表示的原子团作为其亲水部分:其中X1和X2中至少一个表示电子吸引连接基团,条件是当X1和X2中至少一个不是连接基团时,X1和X2中的至少一个表示电子吸引取代基;R1表示氢原子或取代基;M表示氢原子或金属原子。
  • NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
    申请人:Saksena Anil K.
    公开号:US20110117057A1
    公开(公告)日:2011-05-19
    The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    本发明披露了具有HCV蛋白酶抑制活性的新化合物,以及制备这些化合物的方法。在另一种实施方式中,本发明披露了包含这些化合物的制药组合物,以及使用它们治疗与HCV蛋白酶相关的疾病的方法。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐